- Home
- Platforms
- GlycoNano™ Platform
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber Production Service
The Power of Precision: Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber Production
Glycol nanocrystals, nanosheets, nanospheres, and nanofibers are a new type of functional materials, with unique physical and chemical properties, showing great application potential in many fields. With our comprehensive GlycoNano™ Platform, we use advanced technology to provide clients with glycol nanocrystals, nanosheets, nanospheres, and nanofibers production services. Our services are as follows:
Different Nanomaterial Production
Glycol nanocrystal production: We help clients produce PEGylated magnetic zinc-manganese ferrite nanocrystals with methoxy termini, carboxyl termini, or amino termini. These nanocrystals have excellent water solubility, anti-macrophage phagocytosis, long circulation in vivo, and passive tumor targeting. The carboxyl termini are coupled with corresponding antibodies to construct targeted nanoprobes for targeted imaging and molecular imaging research, magnetic induction tumor hyperthermia research, targeted drug carrier research, etc.
Carboxy-terminal PEGylated Magnetic Manganese-Zinc Ferrite Nanocrystal
Amino-terminal PEGylated Magnetic Manganese Zinc Ferrite Nanocrystal
Methoxy-terminal PEGylated Magnetic Manganese Zinc Ferrite Nanocrystal
Glycol nanosheet production: We help clients produce galactose-modified titanium dioxide nanosheets and galactose-modified molybdenum disulfide nanosheets from milligrams to gram levels. Galactose modification enhances the biocompatibility and functionalization possibilities of titanium dioxide nanosheets and molybdenum disulfide nanosheets, making them useful in drug delivery systems.
Galactose-modified Titanium Dioxide Nanosheet
Galactose-modified Molybdenum Disulfide Nanosheet
Glycol nanosphere production: We provide clients with chitosan nanosphere production services with good biocompatibility and biodegradability, which are widely used in drug concentration systems, tissue engineering, and biosensors.
Glycol nanofiber production: We provide clients with cyclodextrin-modified nanofiber membrane materials with microporous structures, which have a wide range of uses in membrane filtration, membrane separation, environmental protection, seawater desalination, biomedicine, and other fields. The nanofiber membrane materials we develop include but are not limited to:
Core-Shell Nanofiber Membrane with Cyclodextrin Polyrotaxane Molecular Channel
β-Cyclodextrin/Polyacrylate Nanofiber Membrane
Polyacrylonitrile (Pan) and β-Cyclodextrin Composite Nanofiber Membrane
Different Nanomaterial Characterization
We use a variety of advanced technical means and equipment to comprehensively analyze and identify the structure, chemistry, and physical properties of nanomaterials. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) provide high-resolution images for observing the surface morphology and microstructure of materials. X-ray diffraction (XRD) is used to analyze the crystal structure of materials and help determine the crystal size and purity. Fourier transform infrared spectroscopy (FTIR) and Raman spectroscopy are used to detect the molecular chemical bonds of materials and their characteristics. Dynamic light scattering (DLS) is used to measure the particle size distribution and dispersion stability of nanomaterials.
Workflow

Applications
- Nanocrystals, nanosheets, nanospheres, and nanofibers are used in drug delivery systems, where their specific size and shape enable precise positioning and controlled release, improving efficacy and reducing side effects.
- Glycol nanosheets and nanofibers are used to develop high-performance, flexible, and lightweight materials for components such as sensors, transistors, and batteries.
- The excellent adsorption properties of glycol nanocrystals and nanospheres make them of great application value in water purification and air filtration systems, effectively removing pollutants.
Advantages
- We integrate advanced nanomaterial production technology to ensure the high purity and consistency of products. This advantage allows us to customize various specifications of nanomaterials according to the specific needs of clients.
- We help clients develop highly functional glycol nanomaterials for multiple application areas such as catalysts, drug delivery systems, and wastewater treatment.
- Our team assists in all processes such as material selection, process design, and production integration, and is ready to solve various problems encountered in development and production.
Publication Data
DOI: 10.3390/app12020771
Journal: Applied Sciences
Published: 2022
IF: 2.5
Results: The authors attempted to prepare formulations for bioprinting applications by connecting different concentrations of cellulose nanocrystals (CNC), alginate (Alg), and polyethylene glycol diacrylate (PEGDA) using a double network crosslinking technique. The morphology, rheological properties, storage modulus, loss modulus, physical properties, quasi-elastic structure, swelling properties, etc. of the double network hydrogel CNC/Alg/PEGDA were then analyzed. In conclusion, the presence of CNC in the double network hydrogel showed a positive effect on the production of 3D bioprinted scaffolds.
Fig.1 Schematic illustration of the manual extrusion process of CNC/Alg/PEGDA formulations. (Asohan, et al., 2022)
Frequently Asked Questions
- How to choose the right nanomaterial for your application?
First, clarify the specific needs and application scenarios. For example, nanocrystals are suitable for applications that require high strength and durability, while nanosheets are suitable for catalysis and sensing. Secondly, understand the chemical and physical properties of the material, including its electrical conductivity, thermal conductivity, biocompatibility, etc. Finally, our experts communicate with clients to provide targeted advice and solutions to ensure that the selected nanomaterials meet your application requirements to the greatest extent. -
What are the challenges in the production process of glycol nanocrystal/nanosheet/nanosphere/nanofiber?
The first is the consistency and purity of the materials. We strictly monitor each batch of production materials. Secondly, the quality control of the production process to prevent the contamination of nanomaterials. We have laboratories and monitoring processes that meet production conditions to ensure material performance.
CD BioGlyco fully understands the specific advantages of each type of glycol nanomaterial and helps clients develop specific nanomaterials that meet their needs. Please feel free to contact us.
Reference
- Asohan, A.W.; et al. Preparation and characterisation of cellulose nanocrystal/alginate/polyethylene glycol diacrylate (CNC/Alg/PEGDA) hydrogel using double network crosslinking technique for bioprinting application. Applied Sciences. 2022, 12(2): 771.
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





